Table III.
Index | Groups | No. of rats | 2 h | 6 h | 24 h |
---|---|---|---|---|---|
MDA | Con | 6 | 4.07±1.21 | 4.25±1.02 | 4.01±1.36 |
MDA | IR | 6 | 16.81±4.17a | 27.43±5.09a | 14.95±2.31a |
MDA | Mino | 6 | 9.52±2.14a,b | 15.23±2.97a,b | 8.47±1.91a,b |
MPO | Con | 6 | 1.01±0.98 | 1.98±1.20 | 0.96±3.17 |
MPO | IR | 6 | 5.31±5.47a | 7.28±1.76a | 4.96±2.17a |
MPO | Mino | 6 | 2.98±0.79a,b | 3.47±3.70a,b | 2.20±4.25a,b |
P<0.05 vs. control group;
P<0.05 vs. I/R group. Data are mean ± standard deviation, mg of protein/ml. MDA, methane dicarboxylic aldehyde; MPO, myeloperoxidase; Con, control sham-operated group; I/R, ischemia/reperfusion; Mino, minocycline.